In last trading session, Biofrontera Inc (NASDAQ:BFRI) saw 0.45 million shares changing hands with its beta currently measuring 0.44. Company’s recent per share price level of $0.88 trading at -$0.11 or -10.77% at ring of the bell on the day assigns it a market valuation of $6.84M. That closing price of BFRI’s stock is at a discount of -359.09% from its 52-week high price of $4.04 and is indicating a premium of 30.68% from its 52-week low price of $0.61. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.77 million shares which gives us an average trading volume of 2.79 million if we extend that period to 3-months.
For Biofrontera Inc (BFRI), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.07 in the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Biofrontera Inc (NASDAQ:BFRI) trade information
Upright in the red during last session for losing -10.77%, in the last five days BFRI remained trading in the green while hitting it’s week-highest on Tuesday, 11/26/24 when the stock touched $0.88 price level, adding 16.98% to its value on the day. Biofrontera Inc’s shares saw a change of -68.11% in year-to-date performance and have moved 16.39% in past 5-day. Biofrontera Inc (NASDAQ:BFRI) showed a performance of -5.41% in past 30-days. Number of shares sold short was 0.46 million shares which calculate 0.08 days to cover the short interests.
Biofrontera Inc (BFRI) estimates and forecasts
Statistics highlight that Biofrontera Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -14.23% of value to its shares in past 6 months, showing an annual growth rate of 81.39% while that of industry is 17.70. Apart from that, the company came raising its revenue forecast for fiscal year 2024. This year revenue growth is estimated to rise 15.38% from the last financial year’s standing.
2 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 14.53M for the same. And 2 analysts are in estimates of company making revenue of 11.5M in the next quarter. Company posted 10.6M and 7.91M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 7.90% during past 5 years.
Biofrontera Inc (NASDAQ:BFRI)’s Major holders
Insiders are in possession of 32.06% of company’s total shares while institution are holding 20.68 percent of that, with stock having share float percentage of 30.44%. Investors also watch the number of corporate investors in a company very closely, which is 20.68% institutions for Biofrontera Inc that are currently holding shares of the company.
On the other hand, Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 15.14 shares of worth $13624.0 or 0.20% of the total outstanding shares. The later fund manager was in possession of 8.61 shares on Jun 30, 2024 , making its stake of worth around $7749.0 in the company or a holder of 0.11% of company’s stock.
